Publication: Inotropic actions of lignocaine and phenytoin
Issued Date
1971-01-01
Resource Type
ISSN
14765381
00071188
00071188
Other identifier(s)
2-s2.0-0015155627
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
British Journal of Pharmacology. Vol.43, No.3 (1971), 483-496
Suggested Citation
BARBARA L. KENNEDY, CHONGKOL NOOKHWUN, CHIRAVAT SADAVONGVIVAD, S. TANCHAJJA Inotropic actions of lignocaine and phenytoin. British Journal of Pharmacology. Vol.43, No.3 (1971), 483-496. doi:10.1111/j.1476-5381.1971.tb07179.x Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/8850
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Inotropic actions of lignocaine and phenytoin
Other Contributor(s)
Abstract
The inotropic effects of two antiarrhythmic drugs, lignocaine and phenytoin, were studied in electrically driven isolated rabbit atrial preparations. The time‐effect relationship of each drug was investigated with different concentrations and frequencies of stimulation. The effects of time of exposure, drug concentration and heart rate on the development of beat alterations (cessation of beat, skipped beat, alternating variation of force of contraction and extrasystole) were also studied. When the chronotropic effects of both drugs were prevented, the inotropic effects were positive or negative depending on the concentration of drug, time of exposure and frequency of stimulation. At concentrations higher than those obtained in the blood of man on maintenance doses, alteration of the beat occurred but was consistent with the peak blood concentrations immediately after the injection of standard clinical doses. The time of onset of beat alteration shortened when either drug concentration or frequency of stimulation was increased. The beat alteration produced by antiarrhythmic drugs can account for various adverse effects associated with their clinical use. These effects include transient ventricular tachycardia and extrasystole during and shortly after injection of drug, ventricular tachycardia, ventricular fibrillation and cardiac arrest due either to excessive dose or to persistent tachyarrhythmia if the dose is not excessive. 1971 British Pharmacological Society